| 000 | 01149 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514020733.0 | ||
| 264 | 0 | _c20020322 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0143-3636 | ||
| 024 | 7 |
_a10.1097/00006231-200201000-00013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRamamoorthy, N | |
| 245 | 0 | 0 |
_aProduction logistics and radionuclidic purity aspects of 153Sm for radionuclide therapy. _h[electronic resource] |
| 260 |
_bNuclear medicine communications _cJan 2002 |
||
| 300 |
_a83-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 |
_aEuropium _xchemistry |
| 650 | 0 | 4 | _aNeutron Activation Analysis |
| 650 | 0 | 4 |
_aRadioisotopes _xtherapeutic use |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xchemistry |
| 650 | 0 | 4 |
_aSamarium _xchemistry |
| 650 | 0 | 4 | _aSpectrometry, Gamma |
| 700 | 1 | _aSaraswathy, P | |
| 700 | 1 | _aDas, M K | |
| 700 | 1 | _aMehra, K S | |
| 700 | 1 | _aAnanthakrishnan, M | |
| 773 | 0 |
_tNuclear medicine communications _gvol. 23 _gno. 1 _gp. 83-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006231-200201000-00013 _zAvailable from publisher's website |
| 999 |
_c11661239 _d11661239 |
||